CD8A and neoplasm: Results revealed that dying tumor cells undergoing ICD could be further filled with adjuvant nano-depots to successfully initiate antigen cross-presentation by dendritic cells and activate potent antigen-specific CD8α+ T cells in mice model bearing CRC.